Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Correspondence
  • Published:

Identification of an HLA-A1 restricted CTL epitope from Mcl-1

Leukemia volume 19, pages 1084–1085 (2005)Cite this article

TO THE EDITOR

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

References

  1. Mocellin S, Semenzato G, Mandruzzato S, Riccardo RC . Part II: vaccines for haematological malignant disorders. Lancet Oncol 2004; 5: 727–737.

    Article  CAS  Google Scholar 

  2. Shangary S, Johnson DE . Recent advances in the development of anticancer agents targeting cell death inhibitors in the Bcl-2 protein family. Leukemia 2003; 17: 1470–1481.

    Article  CAS  Google Scholar 

  3. Andersen MH, Becker JC, thor Straten P . The anti-apoptotic member of the Bcl-2 family Mcl-1 is a CTL target in cancer patients. Leukemia 2005; 19: 484–485.

    Article  CAS  Google Scholar 

  4. Andersen MH, Tan L, Sondergaard I, Zeuthen J, Elliott T, Haurum JS . Poor correspondence between predicted and experimental binding of peptides to class I MHC molecules. Tissue Antigens 2000; 55: 519–531.

    Article  CAS  Google Scholar 

  5. Campoli M, Chang CC, Ferrone S . HLA class I antigen loss, tumor immune escape and immune selection. Vaccine 2002; 19 (Suppl 4): A40–A45.

    Article  Google Scholar 

Download references

Acknowledgements

We thank Merete Jonassen for excellent technical assistance. We thank Professor A Svejgaard and Ms Bodil K Jakobsen, Department of Clinical Immunology, University Hospital, Copenhagen, for HLA-typing of patient blood samples. Supported by grants from the Danish Medical Research Council, The Novo Nordisk Foundation, The Danish Cancer Society, The John and Birthe Meyer Foundation, Danish Cancer Research Foundation.

Author information

Authors and Affiliations

  1. Tumor Immunology Group, Institute of Cancer Biology, Danish Cancer Society, Dk-2100, Copenhagen, Denmark

    M H Andersen, P Kvistborg & P thor Straten

  2. Department of Dermatology, University of Würzburg, D-97080, Würzburg, Germany

    J C Becker

Authors
  1. M H Andersen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P Kvistborg
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J C Becker
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. P thor Straten
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M H Andersen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Andersen, M., Kvistborg, P., Becker, J. et al. Identification of an HLA-A1 restricted CTL epitope from Mcl-1. Leukemia 19, 1084–1085 (2005). https://doi.org/10.1038/sj.leu.2403743

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2403743

This article is cited by

Search

Advanced search

Quick links